Vor Biopharma Inc (VOR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VOR Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Vor Biopharma Inc.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent466.10
Marketable Securities, Current SH358.27
Cash & Short-term Investments824.00
Other Current Assets0.00
Prepaid Expense, Current AS5.88
Total Current Assets475.11
Equipment/Property/Plant Net0.74
Other Assets, Noncurrent5.21
Restricted Cash Equivalents Current-
Restricted Cash Equivalents Noncurrent0.17
Operating Lease Right Of Use Asset2.83
Total Assets481.05
Liabilities
Accounts Payable, Current AC4.00
Accrued Liabilities, Current AC20.48
Other Liabilities, Current0.34
Total Current Liabilities24.81
Total Long-term Debt0.00
Other liabilities, Noncurrent656.44
Operating Lease Liability Current0.31
Total Liabilities681.25
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,236.07
Retained Earnings / Accumulated Deficit-1,435.37
Accumulated Other Comprehensive Income-0.92
Other Equity-0.92
Common Stockholder's Equity-200.20
Total Stockholder's Equity-200.20
Liabilities & Stockholder's Equity481.05
4 historic quarters locked

Sign in to unlock the full Vor Biopharma Inc balance sheet history.

About Vor Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 11, 2026
  • Source: vor-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-343607

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.